Englander Institute for Precision Medicine

"PSKH1 kinase activity is differentially modulated via allosteric binding of Ca²⁺ sensor proteins"

Title"PSKH1 kinase activity is differentially modulated via allosteric binding of Ca²⁺ sensor proteins"
Publication TypeJournal Article
Year of Publication2025
AuthorsHorne CR, Dite TA, Young SN, Mather LJ, Dagley LF, Johnson JL, Yaron-Barir TM, Huntsman EM, Daly LA, Byrne DP, Cadell AL, Ng BH, Yousef J, Multari DH, Shen L, McAloon LM, Manning G, Febbraio MA, Means AR, Cantley LC, Tanzer MC, Croucher DR, Eyers CE, Eyers PA, Scott JW, Murphy JM
JournalProc Natl Acad Sci U S A
Volume122
Issue8
Paginatione2420961122
Date Published2025 Feb 25
ISSN1091-6490
KeywordsAllosteric Regulation, Calcium, Calcium-Binding Proteins, Calmodulin, HEK293 Cells, Humans, Protein Binding, Protein Serine-Threonine Kinases
Abstract

Protein Serine Kinase H1 (PSKH1) was recently identified as a crucial factor in kidney development and is overexpressed in prostate, lung, and kidney cancers. However, little is known about PSKH1 regulatory mechanisms, leading to its classification as a "dark" kinase. Here, we used biochemistry and mass spectrometry to define PSKH1's consensus substrate motif, protein interactors, and how interactors, including Ca2+ sensor proteins, promote or suppress activity. Intriguingly, despite the absence of a canonical Calmodulin binding motif, Ca2+-Calmodulin activated PSKH1 while, in contrast, the ER-resident Ca2+ sensor of the Cab45, Reticulocalbin, Erc55, Calumenin (CREC) family, Reticulocalbin-3, suppressed PSKH1 catalytic activity. In addition to antagonistic regulation of the PSKH1 kinase domain by Ca2+ sensing proteins, we identified UNC119B as a protein interactor that activates PSKH1 via direct engagement of the kinase domain. Our findings identify complementary allosteric mechanisms by which regulatory proteins tune PSKH1's catalytic activity and raise the possibility that different Ca2+ sensors may act more broadly to tune kinase activities by detecting and decoding extremes of intracellular Ca2+ concentrations.

DOI10.1073/pnas.2420961122
Alternate JournalProc Natl Acad Sci U S A
PubMed ID39964718
Grant List1172929 / / Federal Government | DHAC | National Health and Medical Research Council (NHMRC) /
9000719 / / Federal Government | DHAC | National Health and Medical Research Council (NHMRC) /

Weill Cornell Medicine Englander Institute for Precision Medicine 413 E 69th Street
Belfer Research Building
New York, NY 10021